Sustained clinically inactive diseasec · children and young people with JIA
Oral methotrexate plus intra‐articular glucocorticoid showed no clear difference in sustained clinically inactive diseaseb(12 months) compared with intra‐articular glucocorticoid alone (low certainty).
1 finding from 1 review
Sustained clinically inactive diseasec · children and young people with JIA
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Sustained clinically inactive diseasec · children and young people with JIA
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Change in pain Visual Analog Scale (VAS) at 12 weeks (0 to 10 scale; lower score means less pain) · people with rheumatoid arthritis
It is very uncertain whether the intervention changes change in pain Visual Analog Scale (VAS) at 12 weeks (0 to 10 scale;… (very low certainty).
1 finding from 1 review
Intervention not reported
Change in measure of disease activity Disease Activity Score (DAS‐28‐ESR) at 12 weeks (0 to 10 score; lower score means less disease activity) · people with rheumatoid arthritis
It is very uncertain whether the intervention changes change in measure of disease activity Disease Activity Score… (very low certainty).
1 finding from 1 review
Intervention not reported
Change in function Health Assessment Questionnaire (HAQ) at 12 weeks (0 to 3 score; lower score means better function) · people with rheumatoid arthritis
It is very uncertain whether the intervention changes change in function Health Assessment Questionnaire (HAQ) at 12 weeks… (very low certainty).
1 finding from 1 review
Intervention not reported
Radiographic progression · people with rheumatoid arthritis
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Short‐term serious adverse events · people with rheumatoid arthritis
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Long‐term adverse effects or toxicity · people with rheumatoid arthritis
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Withdrawals – overall (at 8 to 12 weeks) · people with rheumatoid arthritis
The intervention may leads to lower withdrawals – overall (at 8 to 12 weeks) (low certainty).
1 finding from 1 review